BioSpace News Archive

Business

Theravance Biopharma, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today reported financial results for the third quarter of 2021.

November 3, 2021
·
15 min read
Business

Tandem Diabetes Care Announces Third Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, reported its financial results for the quarter ended September 30, 2021 and updated its sales guidance for the year ending December 31, 2021.

November 3, 2021
·
12 min read
FDA

TecTraum’s pro2cool® Receives FDA Designation as a Breakthrough Device for the Treatment of Concussions

TecTraum’s pro2cool ® Receives FDA Designation as a Breakthrough Device for the Treatment of Concussions

November 3, 2021
·
4 min read
Pharm Country

Outlook Therapeutics to Present at the Eyecelerator@AAO 2021 Conference Retina Showcases Outlook Therapeutics management to present on Thursday, November 11, 2021

Outlook Therapeutics, Inc. today announced that C. Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, will present at the Eyecelerator@AAO 2021 Conference Retina Showcases being held in New Orleans, Louisiana.

November 3, 2021
·
1 min read
Deals

Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business

Cytek Biosciences today announced that it has acquired the cell analysis business of Tonbo Biosciences™

November 3, 2021
·
5 min read
SOTIO to Present New Data from Phase 1 Study of IL-15 Superagonist, SOT101, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

SOTIO will present three posters discussing data that highlight the encouraging safety and efficacy for SOT101 (SO-C101) as a monotherapy and in combination with pembrolizumab for the treatment of advanced solid tumors

November 3, 2021
·
2 min read
Business

Imcyse Appoints Gene Mack, MBA as Chief Financial Officer

Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, announced the appointment of Gene Mack, MBA, as Chief Financial Officer.

November 3, 2021
·
3 min read
Business

89bio Announces Appointment of Kathy LaPorte to its Board of Directors

89bio, Inc. today announced the appointment of Kathy LaPorte to its Board of Directors, effective immediately.

November 3, 2021
·
2 min read
Business

Acepodia Strengthens Board of Directors and Scientific Advisory Board with Key Appointments

Acepodia today announced the appointments of Robin Andrulevich to the company’s Board of Directors and Eileen Higham, Ph.D., to the company’s Scientific Advisory Board.

November 3, 2021
·
3 min read
Business

BioDelivery Sciences Reports Solid Third Quarter 2021 Results

BioDelivery Sciences International, Inc. today reported solid financial results for the third quarter ended September 30, 2021, including the following operational and performance highlights.

November 3, 2021
·
14 min read